Department of Psychiatry, Johns Hopkins University School of Medicine, Baltimore, MD 21231, USA.
J Pediatr Health Care. 2012 Mar;26(2):139-45. doi: 10.1016/j.pedhc.2011.10.009.
The Food and Drug Administration has approved the use of antipsychotic medications in some children and adolescents with severe emotional and behavioral disorders. However, recent national data show a dramatic rise in off-label and Food and Drug Administration-approved uses of these medications. Of particular note is a twofold to fivefold increase in the use of antipsychotic medications in preschool children, despite little information on their long-term effects. This article describes the trend in pediatric antipsychotic medication use, possible explanations for the increase, implications for children's health, and recommendations for pediatric providers who work with parents of children and adolescents who seek or receive antipsychotic medication treatments.
美国食品和药物管理局已批准将抗精神病药物用于一些患有严重情绪和行为障碍的儿童和青少年。然而,最近的全国数据显示,这些药物的非适应证使用和经美国食品和药物管理局批准的适应证使用急剧增加。特别值得注意的是,尽管关于其长期影响的信息很少,但在学龄前儿童中使用抗精神病药物的情况增加了两倍至五倍。本文描述了儿科抗精神病药物使用的趋势、增加的可能原因、对儿童健康的影响,以及为与寻求或接受抗精神病药物治疗的儿童和青少年的父母合作的儿科医生提供的建议。